Interviews

Larry J. Diaz-Sandoval, MD, discusses the latest clinical results for and trends in the use of renal artery interventions.

The injectable foam Varithena was recently approved by the FDA for treatment of varicose veins. Vascular Disease Management speaks about the therapy with Dr. Marlin Schul, who participated in a trial that led to its approval.

At the 15th annual New Cardiovascular Horizons meeting in New Orleans, Dr. Mena presented information on below-the-knee endovascular solutions as well as laser therapy for in-stent restenosis. Vascular Disease Management spoke with Dr. Mena...

Ramesh K. Tripathi, MD, launched a comprehensive vascular clinic in India. Vascular Disease Management spoke with him about the clinic and the current state of vascular medicine in India.

Vascular Disease Management spoke with Aref Rahman, MD, about the use of the newly launched Mynx Ace Vascular Closure Device, a vascular closure product with a new deployment system to seal femoral artery access sites.

Vascular Disease Management spoke with ENGAGE investigator Dittmar Böckler, MD, PhD, about 3-year results from the 500-patient registry study of the Endurant II AAA stent graft (Medtronic).

Vascular Disease Management spoke with Dr. Glickman about results of a 138-patient study on the Acuseal graft at the 2013 VEITHsymposium meeting.

The Valiant Mona LSA stent graft system is the first device of its kind to be studied in humans as part of the FDA’s Innovation Pathway early feasibility pilot program.

At the 2013 VEITHsymposium, Vascular Disease Management spoke with Eugene J. Simoni, MD, about results of the PEARL registry, which studied hemodialysis patients treated with mechanical thrombectomy.

The Prospective Randomized Endovascular Therapy in MS (PREMiSe) trial studied balloon angioplasty for the treatment of multiple sclerosis. Vascular Disease Management spoke about the results with Robert Zivadinov, MD, PhD, one of the lead...